Cite
HARVARD Citation
Kunz, P. et al. (2023). Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). Journal of clinical oncology. 41 (7), pp. 1359-1369. [Online].